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MaOBJECTIVES This study hypothesized that bright spots in intravascular optical coherence tomography (IVOCT) images
may originate by colocalization of plaque materials of differing indexes of refraction. To quantitatively identify bright
spots, we developed an algorithm that accounts for factors including tissue depth, distance from light source, and signal-
to-noise ratio. We used this algorithm to perform a bright spot analysis of IVOCT images and compared these results with
histological examination of matching tissue sections.
BACKGROUND Bright spots are thought to represent macrophages in IVOCT images, and studies of alternative
etiologies have not been reported.
METHODS Fresh human coronary arteries (n ¼ 14 from 10 hearts) were imaged with IVOCT in a mock catheterization
laboratory and then processed for histological analysis. The quantitative bright spot algorithm was applied to all images.
RESULTS Results are reported for 1,599 IVOCT images co-registered with histology. Macrophages alone were
responsible for only 23% of the bright spot–positive regions, although they were present in 57% of bright spot–positive
regions (as determined by histology). Additional etiologies for bright spots included cellular ﬁbrous tissue (8%), inter-
faces between calcium and ﬁbrous tissue (10%), calcium and lipids (5%), and ﬁbrous cap and lipid pool (3%). Addi-
tionally, we showed that large pools of macrophages in CD68þ histology sections corresponded to dark regions in
comparative IVOCT images; this is due to the fact that a pool of lipid-rich macrophages will have the same index of
refraction as a pool of lipid and thus will not cause bright spots.
CONCLUSIONS Bright spots in IVOCT images were correlated with a variety of plaque components that cause sharp
changes in the index of refraction. Algorithms that incorporate these correlations may be developed to improve the
identiﬁcation of some types of vulnerable plaque and allow standardization of IVOCT image interpretation. (J Am Coll
Cardiol Img 2015;8:63–72) © 2015 by the American College of Cardiology Foundation.I ntravascular optical coherence tomography(IVOCT) is the highest resolution technique avail-able to image vulnerable plaque in coronary ar-
teries (1). In 2003, Tearney et al. (2) published a
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ABBR EV I A T I ON S
AND ACRONYMS
IR = index of refraction
IVOCT = intravascular optical
coherence tomography
LAD = left anterior
descending artery
NSD = normalized standard
deviation
RCA = right circumﬂex artery
SNR = signal-to-noise ratio
TCFA = thin-cap ﬁbroatheroma
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64Concerns have been raised about the
speciﬁcity of bright spots in identifying
macrophages, despite the use of shadowing
behind the bright spots as a secondary
conﬁrmation of macrophage identiﬁcation
(1). For example, other plaque components
appear to cause bright spots, including ﬁbrin
accumulations (9), neoatherosclerosis in
previously placed stents (9), elastic lamina,
cholesterol crystals, and microcalciﬁcations
(1,10). Furthermore, the NSD method was
designed to be accurate only in ﬁbrous caps
and does not apply to the detection of mac-rophages in deeper arterial structures (2).Tearney et al. (2) proposed that regions of high NSD
represent areas in which the optical index of refrac-
tion (IR) has a higher heterogeneity; macrophages
appear as bright spots because of the difference in IR
between them and the surrounding ﬁbrous tissue.
Using this hypothesis, we proposed that bright spots
can arise from constituents other than macrophages
in which a sharp change in IR occurs at interfaces
between plaque components. This sharp change in IR
occurs in multiple scenarios: lipid (IR 1.33) mixed
with calciﬁed cores (IR 1.65), lipid mixed with ﬁbrous
tissue (IR 1.47), and cellular ﬁbrous tissue rich
in proteoglycans (IR 1.33)—each of which may
generate bright spots in IVOCT images on the basis
of this hypothesis.
We developed an algorithm that can be applied to
the entire depth of the artery to enable quantitative
identiﬁcation of bright spots in IVOCT images of hu-
man atherosclerotic plaque. In the present study, we
used this algorithm to analyze bright spots in images
of human atherosclerotic plaque and compared these
results with those of corresponding histological sec-
tions. In addition, we further examined the hypoth-
esis that abrupt changes in plaque components of
differing IR result in the generation of bright spots in
IVOCT images.
METHODS
SPECIMENS. Ten human hearts (from 3 women and 7
men) at autopsy within 24 h of death were examined.
The average age at death was 65  11 years. The cause
of death was cardiac in 6 cases. We imaged 14 coro-
nary arteries (10 left anterior descending arteries
[LADs] and 4 right coronary arteries [RCAs]). The
institutional review board at the University of Texas
approved this study.
IMAGING PROCEDURE. The human heart catheteri-
zation laboratory was recreated with a custom IVOCT
SEE PAGE 73system (Volcano Corporation, San Diego, California)
to access the raw signal data. The IVOCT system has a
1,310-nm swept source laser (HSL-1000, Santec,
Hackensack, New Jersey) and a bandwidth of 80 nm
scanning at a repetition rate of 34 kHz. The measured
free-space axial resolution was 20 mm with a 2.8-mm
scan depth. The IVOCT signal was sampled with a
linear k-space clock to allow real-time OCT image
acquisition and display. A ﬂuoroscopy system (GE
Healthcare, Little Chalfont, United Kingdom) and a
chamber designed to maintain the tissue at 37C were
used. Left and right coronary 6-F guide catheters
were sewn into the coronary ostia, 0.014-inch guide-
wire access to the coronary arteries was gained under
ﬂuoroscopic guidance, and a stent was deployed 80
mm from the guide catheter tip as a ﬁduciary marker.
IVOCT pullbacks were acquired from the stent to the
guide catheter (80-mm total pullback length). The
LAD and RCA were imaged. Following imaging, the
RCA and LAD were perfusion-ﬁxed with formalin at
100 mm Hg. The left circumﬂex artery was not imaged
due to its tortuosity in the ex vivo heart.
HISTOLOGY. The LADs and RCAs were perfusion-
ﬁxed with 10% neutral-buffered formalin, excised
from each heart, individually radiographed on a Faxi-
tron MX-20 (Faxitron Bioptics LLC, Tucson Arizona),
and decalciﬁed overnight with Cal-Rite (Richard Allen
Scientiﬁc, Kalamazoo, Michigan), if necessary. The
arterial segments were sliced into 2- to 3-mm–thick
rings and further processed on a Tissue-Tek vacuum
inﬁltration processor (Sakura Finetek USA, Torrance,
California) for standard parafﬁn-embedded sections.
An average of 25 rings was generated from each
artery. Serial tissue sections (5-mm thick) were cut at
150-mm intervals and stained with hematoxylin and
eosin, modiﬁed Movat pentachrome, and Von Kossa.
Anti-CD68 (Dako North America, Inc., Carpinteria,
California) and anti–alpha smooth muscle cell actin
(Sigma-Aldrich, St. Louis, Missouri) antibodies were
used in immunohistochemical studies to identify
macrophages and smooth muscle cells, respectively.
IVOCT AND HISTOLOGY CO-REGISTRATION. Each
histological ring was matched to a respective IVOCT
frame. Co-registration was performed between IVOCT
images and histological sections on the basis of the
following: 1) 2 ﬁducial landmarks—a stent deployed at
the distal end of the pullback and the sewn-in guide
catheter at the proximal edge—that were visible
in IVOCT images, ﬂuoroscopy, and radiography
before histopathologic processing; and 2) the phy-
sical position of IVOCT images in the pullbacks
measured against the estimated distance in mi-
crons from the ﬁducial landmarks in the tissue
TABLE 1 Histological Composition of Algorithm-Identiﬁed Bright Spots
When Macrophages Are Present
Bright Spot Source n (%)*
Macrophage-rich areas with ﬁbrous tissue 391 (23.0)
Cholesterol clefts in necrotic cores 16 (0.9)
Areas of layering or interface
Interface of old and new ﬁbrous tissue 25 (1.5)
Intimal/medial or adventitial/medial interface 39 (2.3)
Calcium/ﬁbrous interface 130 (7.6)
Calcium/lipid interface 98 (5.8)
Fibrous cap/lipid pool interface 219 (12.9)
Neovascularization/media interface 48 (2.8)
*Values are percent of total bright spot regions in all intravascular optical coherence tomography
images (N ¼ 1,700).
FIGURE 1 Bright Spot Quantiﬁcation Method
(A) An original B-scan. (B) Algorithm-processed B-scan showing the identiﬁed bright
spots. (C) B-scan from (A) converted to a rectangular view. The blue and green line marks
the tissue lumen identiﬁed by the algorithm. The blue tissue edge identiﬁes A-scans that
are closer than the mean distance to the catheter; the green tissue edge identiﬁes A-scans
further than the mean distance to the catheter. (D) Original B-scan with A-scans aligned at
the blue and green line from C. (E) Averaged A-scans from the blue and green regions
in C. The intensity required to be considered a bright spot decreases with tissue depth and
increases with closeness to the catheter. An example A-scan shown in magenta (A)
compared with the reference value (F). Pixels with intensity greater than the reference
value are marked in red and labeled as bright spots in B.
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65sections. Additionally, anatomic landmarks (e.g.,
arterial branches or calciﬁcation patterns when pre-
sent) and luminal geometric features further aided
co-registration. Two researchers independently co-
registered the IVOCT images and histology, and dis-
crepancies were discussed to ﬁnd agreement between
both co-registrations.
In IVOCT images, bright bands <65 mm thick that
covered diffusely shadowed regions were identiﬁed
as thin-cap ﬁbroatheromas (TCFAs). Histological
TCFAs were identiﬁed by ﬁbrous caps <65 mm thick
that covered lipid or necrotic cores.
HISTOLOGICAL COMPOSITION OF BRIGHT SPOT–
CONTAINING AREAS. Regions within the arterial
wall that elicited bright spots after application of the
algorithm were ﬁrst categorized by whether macro-
phages were present or not. Next, each of these
macrophage-positive or macrophage-negative bright
spot sources were classiﬁed into the following 4
broad categories: 1) hypocellular or acellular collagen-
rich ﬁbrous tissue (mesh-like collagen-rich areas
mixed with lipid or the ﬁbrous cap of ﬁbrocalciﬁc
plaques); 2) cellular ﬁbrous tissue (as found in intimal
thickening or early lesions with high smooth muscle
and proteoglycan content); 3) cholesterol clefts
within necrotic cores; and 4) areas of layering or
interface (as observed in remodeled plaque ruptures,
at the interfaces between calcium and surrounding
tissue, between lipid and calcium in ﬁbrocalciﬁc pla-
ques, at the interface of necrotic or lipid cores and the
overlying ﬁbrous cap, at neovascularization sites and
the media, or at the elastic lamina intimal/medial or
medial/adventitial interface).
BRIGHT SPOT QUANTITATIVE DETECTION. The
detection method is outlined in Figure 1. First, we
measured the distance between the lumen edge and
the catheter for each A-scan per frame. Next, the
mean of those distances was calculated for each
frame. To account for variations in signal intensity
that occur as the catheter moves closer or further
away from the lumen, we calculated 2 reference
A-scans by averaging all A-scans that were less than
or greater than the mean distance to the catheter.
Then, to account for varying signal-to-noise ratio
(SNR), the reference A-scans were normalized
(divided by the difference between the maximum and
minimum values of each frame). We compared each
A-scan to the averaged and normalized reference
A-scan that corresponded to whether its catheter to
lumen edge distance was less than or greater than the
mean; this provided a threshold to identify bright
spots on the basis of tissue depth, distance from
catheter, and SNR of the IVOCT system and catheter.
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66STATISTICS. Four statistical analyses were per-
formed: 1) interobserver and intraobserver variability
between 2 expert IVOCT readers who evaluated the
unprocessed IVOCT frames for identiﬁcation of bright
spots; 2) joint probability of agreement between 1
expert IVOCT reader and the bright spot algorithm;
3) sensitivity and speciﬁcity of 1 expert IVOCT reader
for identifying macrophages compared with the gold
standard of histology; and 4) sensitivity and speci-
ﬁcity of the bright spot algorithm for identifying
macrophages compared with the gold standard of
histology. Sensitivity and speciﬁcity calculationsFIGURE 2 Macrophages Depicted by the Quantitative Bright Spot D
(A) Unprocessed intravascular optical coherence tomography (IVOCT) im
IVOCT image with bright spots identiﬁed. (C) Normalized SD (NSD) imag
phages. (E) Unprocessed IVOCT image with bright spots (yellow arrows
processed IVOCT image with bright spots identiﬁed. (G) NSD image. (H)
macrophage positivity and that the red circled macrophage pool was de
region with macrophages far from the catheter. (J) Algorithm-processed
region. (K) NSD image. (L) CD68 stains showing macrophage positivity in
to identify bright spots. All scale bars are 1 mm.were performed at 2 depths, superﬁcial (<100 mm)
and deep (>100 mm).
RESULTS
We imaged 14 coronary arteries (10 LADs and 4 RCAs)
from 10 human hearts, generating 300 IVOCT images
per vessel. After application of the algorithm, we
observed 2,206 IVOCT frames with bright spots. A
total of 1,111 of the IVOCT frames with bright spots
were co-registered with histology, and 1,700 regions
within these 1,111 frames caused distinct sources ofetection Method
age with visible bright spots (red arrows). (B) Algorithm-processed
e. (D) CD68 stain showing that bright spots were caused by macro-
) and shadows (red circles) caused by macrophages. (F) Algorithm-
CD68 stain showing that bright spots came from a region of
picted as a shadow in E and F. (I) Unprocessed IVOCT image from a
IVOCT image showing that bright spots were not found in the CD68þ
the red circle. This region was too far from the catheter for the signal
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67bright spots. A total of 488 IVOCT frames without
bright spots were co-registered to histology for
negative control. See Online Table 1 for the morpho-
logical classiﬁcation of the bright spot locations.
When only the raw, unprocessed IVOCT frames were
reviewed for identiﬁcation of bright spots between 2
expert IVOCT readers, intraobserver variability was
88% and interobserver variability was 76%.
MACROPHAGE DETECTION BY THE BRIGHT SPOT
ALGORITHM. Using our quantitative algorithm and
histological examination, we characterized the role of
macrophages in the origin of bright spots in IVOCT
images (Table 1, Figure 2). Macrophages alone were
responsible for bright spots in 391 regions (23%). A
combination of macrophages and other etiologies
were the source of bright spots in an additional 574
regions (34%). In total, macrophages were present in
57% of bright spot–positive regions. See the Online
Appendix for a description of how NSD images were
generated and for a discussion of the NSD method
compared with our bright spot method for detection
of macrophages.
Large, dense CD68þ areas on histology corre-
sponded to dark regions (Figures 2 and 3) in the
associated IVOCT image (125 of the CD68þ regions).
Additionally, we identiﬁed 61 regions in which mac-
rophages were located too deep in the tissue or too farFIGURE 3 Macrophages That Appear as Dark Regions
Macrophages and macrophage shadows in IVOCT images. (A to C) Unpr
macrophages. Red arrows mark macrophage-rich regions that appear as
Abbreviation as in Figure 2.from an eccentric catheter position to be visualized by
IVOCT (Figure 2I). There were also 89 regions of CD68
positivity in histological sections that did not cause
bright spots and thus were not identiﬁed by the bright
spot algorithm. Lastly, in 186 regions, macrophages
were depicted as bright spots that caused super-
ﬁcial shadowing. Of these 186, 115 (62%) were found
in regions where calcium was colocalized with the
macrophages (Figure 4D) and 4 were in regions
where cholesterol crystals were colocalized with the
macrophages.
The sensitivity and speciﬁcity of the bright spot al-
gorithm compared with an expert IVOCT reader for
identiﬁcation of macrophages, with histology as a gold
standard, are summarized in Table 2. The IVOCT reader
used unprocessed IVOCT images for the analysis. The
algorithm was more sensitive to bright spots (80%),
implying that the presence of macrophages was more
often correctly identiﬁed by the algorithm than by an
expert reader; however, the algorithmwas less speciﬁc
(49%), as anticipated, because it detects sources of
bright spots due to etiologies other than macrophages.
This is also supported by the joint probability of
agreement that was calculated between the algorithm
and expert reader (53%), which reﬂects the fact that
the algorithm identiﬁed regions of macrophages that
the expert IVOCT reader would have missed.ocessed IVOCT images. (D to F) CD68 stain verifying the presence of
dark IVOCT regions, not bright spots. All scale bars are 1 mm.
FIGURE 4 Bright Spots Found Near Calcium
(A) Unprocessed IVOCT image with bright spots caused by calcium mixed with islands of
lipid (red arrows). (B) Algorithm-processed IVOCT image with bright spots identiﬁed. (C)
Hematoxylin and eosin (H&E) stain. (D) Unprocessed IVOCT image with bright spots that
cause shadows like macrophages (pink arrows). (E) Algorithm-processed IVOCT image
with bright spots identiﬁed. (F) CD68 (left) and H&E (right) stains showing that macro-
phages comingled with calcium are the cause of the bright spots with shadowing. All scale
bars are 1 mm unless otherwise noted. Abbreviation as in Figure 2.
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68ALGORITHM IDENTIFIED BRIGHT SPOTS NOT
COLOCALIZED WITH MACROPHAGES. Bright spots
were also associated with ﬁbrous tissue (cellular 8%;
acellular 8%) (Table 3, Figure 5G), areas of plaque
layering between old and new ﬁbrous tissue in
remodeled plaques (4%) (Figure 5A), calciﬁed lipid
cores with noncalciﬁed remaining lipid (5%)
(Figure 4A), and the ﬁbrous cap and lipid pool inter-
face (3%) (Figure 5D).
ALGORITHM IDENTIFIED BRIGHT SPOTS COLOCALIZED
WITH TCFAS. Bright spots occurred in 175 regions of
IVOCT frames morphologically classiﬁed as TCFAs(Table 4). Of these, 165 regions were also colocalized
with CD68 positivity. Figure 6 demonstrates bright
spots originating in a TCFA; the bright spots in
this case were caused by both macrophages in the
ﬁbrous cap and the ﬁbrous cap interface with the
lipid core. There were only 10 regions of bright spots
in TCFA IVOCT frames that were not colocalized with
macrophages (data not shown); of these regions,
the source of bright spots was the ﬁbrous cap and
lipid or necrotic core interface (n ¼ 4), the ﬁbrous
cap and calcium border (n ¼ 3), and acellular ﬁbrous
tissue (n ¼ 3).
DISCUSSION
We conﬁrmed that IVOCT bright spots can be caused
by macrophages; however, we also identiﬁed new
alternative etiologies. Our ﬁndings suggest that
IVOCT bright spots can be generated in areas char-
acterized by sharp changes in IR. Our results support
the principle that spatial gradients in IR are respon-
sible for enhanced light scattering that results in
bright regions in IVOCT images. Thus, most bright
spots in IVOCT images are not caused by macro-
phages but originate from a mixture of atherosclerotic
components that have maximal differences in optical
IR. Of the sources of bright spots identiﬁed, all were
found in regions with known sharp gradients of
IR. In the case of layering between old and new
ﬁbrous tissue, the colocalization of different types
of collagen ﬁbers or the degree of maturation is
responsible for the shift in IR (11). In particular, after a
rupture has healed, collagen type III is replaced by
type I and results in a band of high backscattering
signal between the layers of tissue—this is likely due
to the greater optical density of collagen type I in
comparison to type III (1).
SOME MACROPHAGES APPEAR DARK. Our ﬁnding
that large pools of macrophages appear dark sup-
ports the observation that homogeneous material in
plaque, even groups of macrophages as shown in
this study, can have a homogeneous IR and thus
would not be expected to cause bright spots. More-
over, this ﬁnding implies that a large pool of mac-
rophages that have engulfed lipid (foam cells) will
appear dark on IVOCT images, similar to lipid pools,
and may not be easily identiﬁed by IVOCT (Figures 2
and 3). Thus, the juxtaposition of foam cells with a
low IR next to the ﬁbrous cap with a higher IR may
have been the origin of bright spots identiﬁed in
previous studies (2).
An alternative hypothesis for explaining why not
all macrophages appear as bright spots in IVOCT im-
ages involves differences in macrophage subsets. M1
TABLE 2 Sensitivity and Speciﬁcity of the Bright Spot Algorithm Compared With an
Expert IVOCT Reader for Identiﬁcation of Macrophages Deﬁned by Histology
Macrophage Locations
Algorithm Expert Reader
Sensitivity, % Speciﬁcity, % Sensitivity, % Speciﬁcity, %
All 80 49 46 76
Superﬁcial (<100 mm) 74 49 42 76
Deep (>100 mm) 87 49 52 76
IVOCT ¼ intravascular optical coherence tomography.
TABLE 3 Histological Composition of Algorithm-Identiﬁed
Bright Spots When Macrophages Are Not Present
Bright Spot Source n (%)*
Fibrous tissue
Hypocellular or acellular 141 (8.3)
Cellular 138 (8.1)
Cholesterol clefts in necrotic cores 2 (0.1)
Areas of layering or interface
Interface of old and new ﬁbrous tissue 61 (3.6)
Intimal/medial or adventitial/medial interface 90 (5.3)
Calcium/ﬁbrous interface 162 (9.5)
Calcium/lipid interface 83 (4.9)
Fibrous cap/lipid pool interface 45 (2.6)
Neovascularization/media interface 12 (0.7)
*Values are percent of total bright spot regions in all IVOCT images (N ¼ 1,700).
Abbreviation as in Table 2.
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69macrophages, considered the “classic” phenotype,
are thought to be proinﬂammatory and engulf lipid to
form foam cells, whereas M2 macrophages, consid-
ered anti-inﬂammatory, contain smaller vesicles of
engulfed lipid (12) and a higher density of mito-
chondria (13). Thus, M1 macrophage foam cells may
appear as shadows or dark regions because of the
large amount of intracellular lipid, but M2 macro-
phages may appear bright because of a higher density
of light-scattering mitochondria (14,15). Further study
of how M1 and M2 macrophages appear in IVOCT
images is needed. Additionally, combining IVOCT
with other imaging techniques that have a higher
speciﬁcity for lipid, ﬁbrous tissue, and macrophages,
such as two-photon luminescence (16) or ﬂuorescence
lifetime imaging (17), may provide enhanced con-
trast for distinguishing between the subtypes of
macrophages.
MACROPHAGES ALONE ARE RESPONSIBLE FOR
FEW REGIONS OF BRIGHTNESS. Although 57% of all
regions with algorithm-deﬁned bright spots were
CD68þ, 34% of all regions that were CD68þ were also
colocalized with other tissue components that caused
bright spots in the absence of any macrophages
(Table 3). It is uncertain whether bright spots in the
presence of both macrophages and those other com-
ponents were caused by the macrophages or by
another etiology. Thus, only 23% of the bright spots
were deﬁnitely caused by macrophages.
MECHANISM OF SUPERFICIAL SHADOWING CAUSED
BY MACROPHAGES. In addition to appearing as
bright spots in IVOCT images, macrophages can cause
shadowing that may appear as a lipid pool (1,18).
Although our algorithm for identifying bright spots
does not directly search for shadowing behind the
bright spots, we identiﬁed 186 regions of bright spots
that caused shadows; 119 were located in re-
gions characterized by the colocalization of micro-
calciﬁcation or cholesterol crystals and macrophages
(Figures 4D to 4F). We believe that shadowing was
actually caused by microcalciﬁcation and/or choles-
terol crystals. Considering Mie scattering, which
describes the way light scatters from symmetrical
objects, smaller features with higher IRs will cause
increased shadowing. Thus, small cholesterol crystals
and microcalciﬁcations, both of which have high IRs
compared with the other plaque components, can
cause shadows. In addition to ingesting lipid, mac-
rophages can engulf microcalciﬁcations (19) and
cholesterol crystals (20). Macrophages alone do not
have optical properties that would cause a shadow,
unless they have engulfed a microcalciﬁcation or
plaque component that has an IR substantially higherthan that of lipid. The high IR of cholesterol clefts is
also consistent with the bright spots observed within
necrotic cores. Thus, we propose that the type and
distribution of engulfed material affects the shad-
owing by macrophages.
ALGORITHM-IDENTIFIED BRIGHT SPOTS IN TCFAS. Most
of the bright spot regions found in TCFA IVOCT
frames (165 of 175 regions) were colocalized with
macrophages. Interestingly, the majority were caused
by either macrophage-rich areas with ﬁbrous tissue or
the ﬁbrous cap/lipid pool interface, which is also
where macrophages are often found. Thus, it can be
difﬁcult to distinguish when bright spots found in
TCFAs are caused by macrophages or the ﬁbrous cap/
lipid pool interface.
STATISTICS REGARDING IDENTIFICATION OF
MACROPHAGES. The algorithm was more sensitive
at detecting the true presence of macrophages than
an expert reader, demonstrating its value. This result
is supported by the joint probability of agreement
between the expert IVOCT reader and the algorithm—
only 53%, which quantiﬁes the ﬁnding that the algo-
rithm identiﬁed regions of macrophages that the
expert IVOCT reader missed. The reduced speciﬁcity
of the algorithm was anticipated because it also de-
tects causes of bright spots other than macrophages,
FIGURE 5 Bright Spots Found in Fibrous Tissue
(A) Unprocessed IVOCT image from a region with ﬁbrous tissue layering that generated bright spots. (B) Algorithm-processed IVOCT image
with bright spots identiﬁed. (C) Movat stain showing layering suggestive of a healed rupture. (D) Unprocessed IVOCT image from a region with
an interface between ﬁbrous tissue and a long, narrow lipid core. (E) Algorithm-processed IVOCT image with bright spots identiﬁed. (F) H&E
stain showing the ﬁbrous components (asterisks). The lipid core appears as a clear band. (G) Unprocessed IVOCT image from a region of cellular
ﬁbrous intimal thickening that is rich in smooth muscle cells and proteoglycans. (H) Algorithm-processed IVOCT image with bright spots
identiﬁed. (I) Movat stain (left) of the region within the inset showing elastin layers (arrows). CD68 stain (right) showing that this region is
CD68 negative. All scale bars are 1 mm unless otherwise noted. Abbreviations as in Figures 2 and 4.
Phipps et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 1 , 2 0 1 5
IVOCT Bright Spot Quantiﬁcation and Analysis J A N U A R Y 2 0 1 5 : 6 3 – 7 2
70due to differences in IR of comingled plaque compo-
nents, the hypothesis of this paper. The increased
speciﬁcity (76%) of the IVOCT reader showed that an
expert reader can distinguish between bright spots
caused by macrophages and bright spots caused by
other sources. One way to increase the accuracy for
identiﬁcation of macrophages is to allow an expert
reader to sort through the bright spot processed
images and disregard images that have bright
spots obviously not caused by vulnerable plaque
morphologies. Future advances in multimodal or
more advanced image processing methods could
discard regions of brightness from nonvulnerable
plaque types automatically. For example, the accu-
racy of identifying vulnerable plaque could be
improved by combining IVOCT with a novel tech-
nique that provides biochemical speciﬁcity such astime-resolved ﬂuorescence (21) or Raman spectros-
copy (22).
ALGORITHM-IDENTIFIED BRIGHT SPOTS AT THE
LIPID AND CALCIUM INTERFACE. We found that re-
gions with lipid intermingled in ﬁbrocalciﬁc plaque
can also generate bright spots. We believe the
underlying reason for this ﬁnding is that ﬁbro-
calciﬁc plaque shows rich signal heterogeneity within
the calciﬁed cores. Lipid cores initially develop
microcalciﬁcations, which have been associated with
vulnerable plaque (23). These microcalciﬁcations
coalesce into larger calciﬁcations; the intermingling
of lipid with a low IR and microcalciﬁcations with
a high IR is responsible for the complexity and
heterogeneity of some calciﬁcation sites. Once
these cores become homogeneous calciﬁed plates
(24), the bright reﬂections may resolve. However,
FIGURE 6 Bright Spots in TCFA
(A) Unprocessed IVOCT image that was classiﬁed as thin-cap ﬁbroatheroma (TCFA) by
histology. (B) Algorithm-processed IVOCT image with bright spots identiﬁed. (C) H&E stain
showing a TCFA. (D) CD68 stain showing macrophages at the ﬁbrous cap and lipid pool
interface. Abbreviations as in Figures 2 and 4.
TABLE 4 Histological Composition of Algorithm-Identiﬁed
Bright Spots in TCFA When Macrophages Are Present
Bright Spot Source n (%)*
Macrophage-rich areas with ﬁbrous tissue 51 (31)
Cholesterol clefts in necrotic cores 4 (2)
Areas of layering or interface
Interface of old and new ﬁbrous tissue 6 (4)
Intimal/medial or adventitial/medial interface 9 (5)
Calcium/ﬁbrous interface 13 (8)
Calcium/lipid interface 19 (12)
Fibrous cap/lipid pool interface 54 (33)
Neovascularization/media interface 9 (5)
*Values are percent of total regions in IVOCT images with bright spots that are
colocalized with CD68 positivity (n ¼ 165).
TCFA ¼ thin-cap ﬁbroatheroma; other abbreviation as in Table 2.
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71homogeneous calciﬁed plates in the absence of re-
sidual pools of lipid are not frequently found in hu-
man atherosclerosis and are not commonly seen
during OCT imaging.
ADVANTAGES OF OUR BRIGHT SPOT ALGORITHM.
Because current methods for interpreting IVOCT
images are qualitative, interpretation varies widely.
This is especially true when identifying TCFA because
distinguishing lipid from calcium can be difﬁcult
(25–27) and macrophages can cause shadowing that
falsely appears as a lipid core (18). Developing algo-
rithms to quantify plaque composition is critical
if IVOCT is to be used for accurately identifying
plaque composition. Furthermore, several optical
properties must be considered when identifying
IVOCT bright spots. Light attenuates through tissue at
an exponential rate dependent upon both depth and
tissue composition, and the intensity of light re-
ﬂections varies with distance from the catheter.
Finally, the SNR will vary between IVOCT images and
pullbacks due to differences in the power of laser
sources, manufacturing variability between cathe-
ters, and other clinical variables such as residual
blood in the ﬁeld. Thus, tissue depth, distance from
the catheter, and the SNR are factors that should be
considered when identifying IVOCT bright spots, and
all are taken into account with the bright spot algo-
rithm presented here.
STUDY LIMITATIONS. Although our study used
algorithm-deﬁned bright spots within IVOCT images
to focus our histology examination, the opposite was
not performed. Second, as with all imaging studies,
histological co-registration is complex, and the pos-
sibility of error exists. Additionally, the histological
sections were 5 mm thick, whereas the IVOCT images
were separated by 270 mm of tissue. However, serial
sectioning throughout the ROIs greatly improved theaccuracy of our co-registration. Lastly, distortions
due to histological processing are always possible
sources of error in co-registration and IVOCT image
interpretation.
CONCLUSIONS
We developed a novel quantitative technique to
identify bright spots in IVOCT images. Our ﬁndings
indicated that not all bright spots are caused
by macrophages; rather they can be generated by a
combination of plaque components that create sharp
changes in the IR. Moreover, we found that macro-
phage foam cells can be seen as dark regions on
IVOCT images. Our study underscores the importance
of developing more discerning algorithms. Software
that incorporates our quantitative technique may
improve the identiﬁcation of some types of vulner-
able plaque and may enable the standardization of
IVOCT image interpretation.
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